NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on ...

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $2.8 million, has surpassed its initial enrollment target for its stroke ...

As you can see from the chart above the percentage of shares that are sold short for Helius Medical Tech has grown since its last report. This does not mean that the stock is going to fall in the ...

(RTTNews) - Helius Medical Technologies (HSDT), a neurotech company focused on innovative treatments for neurological deficits, on Tuesday announced strong progress in its stroke registrational ...

The company will not receive any of the proceeds from the sale of the securities by the selling stockholders. Published first on TheFly – the ultimate source for real-time, market-moving ...

Helius Medical Technologies, Inc. announced agreements with warrant holders to exercise nearly 4.97 million shares of common stock at a reduced price of $0.751 per share, generating approximately ...

This page features the latest news about the Helius Medical A stock. Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 ...

Summary: Helius Medical Technologies Inc. has surpassed initial enrollment targets for its stroke registrational program evaluating PoNS Therapy, a novel neuromodulation approach to improve gait and ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...